drugset / Trial / NCT00049803

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

NCT00049803

Phase 3 Completed 200 enrolled Orphan Medical
RandomizedParallel-groupDouble-blindTreatment

Summary

The initial portion of the protocol involves discontinuing any medications for cataplexy that the patient may be taking. Subsequently, the patient is prescribed a dose of oral solution of study drug or placebo over a 10-11 week period. During the trial, narcolepsy symptoms will be evaluated. Participants are allowed to continue using stimulant medications at constant doses during the study. A total of 1 to 3 daytime visits in addition to 4 overnight visits to the sleep center will be required to complete the study.

Timeline

Start
2000-12
Primary completion
Completion
2004-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Oxybate Unknown 4.5 g Oral
Subject Sodium Oxybate Unknown 6 g Oral
Subject Sodium Oxybate Unknown 9 g Oral

Indications